🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Electroacupuncture as a Treatment for Refractory Overactive Bladder

RecruitingNAAges 18 Years - anyFemaleChelsea and Westminster NHS Foundation Trust
NCT07124390 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study is a single-site feasibility randomised controlled trial evaluating the feasibility and acceptability of electroacupuncture (EA), and percutaneous tibial nerve stimulation (PTNS), in women with refractory overactive bladder (OAB) who have not achieved satisfactory improvement following standard pelvic health physiotherapy. The primary aim is to determine whether a larger definitive trial is feasible by assessing recruitment, consent, retention, treatment adherence, data completeness, intervention delivery, safety, and participant acceptability. Twenty-four participants will be randomly allocated to receive electroacupuncture or PTNS, over a 12-week treatment period. Outcome assessments will be completed at baseline, 6 weeks, 12 weeks, 6 months, and 12 months. The findings will inform the design of a future definitive randomised controlled trial and contribute to the evidenc

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: Participants must meet all of the following criteria: * Female adults aged 18 years or older. * Diagnosed with overactive bladder syndrome (ICIQ-OAB score ≥10). * Symptoms present for at least three months and refractory to first-line treatments. * Willing to refrain from starting new bladder-related treatments during the study period. * Able and willing to provide written informed consent. Exclusion Criteria: * Participants meeting any of the following criteria will be excluded: * Pregnant or planning pregnancy during the study period. * Bleeding disorders. * Severe needle phobia. * Presence of a pacemaker. * Active cancer diagnosis. * Active urinary tract infections or other urological conditions requiring urgent intervention. * Participation in another clinical trial for bladder dysfunction within the past six months. * Neurological conditions affecting continence (e.g., diabetic neuropathy, multiple sclerosis, Parkinson's disease). * Life-threatening infections. * Severe cognitive deficits, unconsciousness, dementia (e.g., Alzheimer's or other neurodegenerative diseases). * History of incontinence surgery. * Previous acupuncture for OAB within the past two months. * History of thromboses. * Recovering from or suffering from a serious illness or major surgery.
💊

What it tests

  • Name: Electroacupuncture (EA) Type: Device-based acupuncture therapy
  • Neuromodulation therapy
📍

Where

1 site
Chelsea and Westminster hospital NHS foundation Trust
London, United Kingdom
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy